Search Results - "Morillo, B. Ortega"

Impact of the COVID-19 Pandemic on a Cancer Fast-Track Programme by Martínez, M. T., Moragon, S., Ortega-Morillo, B., Montón-Bueno, J., Simon, S., Roselló, S., Insa, A., Viala, A., Navarro, J., Sanmartín, A., Fluixá, C., Julve, A., Soriano, D., Buch, E., Peña, A., Franco, J., Martínez-Jabaloyas, J., Marco, J., Forner, M. J., Cano, A., Silvestre, A., Teruel, A, Bermejo, B., Cervantes, A., Chirivella Gonzalez, I.

“…Introduction The COVID-19 pandemic has disrupted many aspects of clinical practice in oncology, particularly regarding early cancer diagnosis, sparking public…”
Get full text

18P In vitro analysis of the combination of APR-246 and carboplatin in triple negative breast cancer (TNBC) and high grade serous ovarian cancer (HGSOC) cell lines and its impact on Aurora kinase A (AURKA)-p53 pathway by Martinez-Pretel, J.J., Pineda, B., Eguez, K., Ortega Morillo, B., Hochstadt, J., Monzon, M., Lluch-Hernandez, A., Cervantes, A., Perez Fidalgo, J.A.

Get full text

538P Single-center retrospective analysis of patients with brain metastases included in early phase clinical trials by Pretelli, G., Laimito, K.I. Rojas, Alonso, G., Bardaji, M.J. Lostes, Calvo, A. Hernando, Galvao, V., Oberoi, A., Morillo, B. Ortega, Santa Gadea, O. Saavedra, Moya, J. Ginard, Manich, C. Saura, Fernandez, M.E. Elez, Ortiz, C., Couselo, E. Muñoz, Braña, I., Perez, A. Callejo, Galceran, J. Carles, Felip, E., Garralda, E., Villar, M. Vieito

Get full text

1624P Impact of the COVID-19 pandemic in the cancer fast-track programme by Martinez, M.T.M., Simón, S., Montón-Bueno, J., Moragón, S., Morillo, B. Ortega, Roselló, S., Navarro, J., Sanmartin, A., Julve, A., Flores, M., Buch, E., Peña, A., Franco, J., Martínez-Jabaloyas, J., Marco, J., Forner, M.J., Cano, A., Bermejo, B., Cervantes, A., Chirivella, I.

Get full text

28P Collagen-activated signalling pathway is significantly hypermethylated in high-grade serous ovarian cancer (HGSOC) patients treated with platinum-containing neoadjuvant chemotherapy (NACT) by Fidalgo, J.A. Perez, Burgues, O., Morillo, B. Ortega, Pretel, J.J. Martinez, Ruiz-Linuesa, M., Barrallo, I. Gonzalez, Sanchez-Serrano, P., Segui-Manzaneque, V., Merlo, B. Pineda

Get full text

93P Evolving landscape of targeted therapies (TT) in early phase clinical trials (EPCT): The RESISTANCE project (360R) by Rossi, A., Braña, I., Villar, M. Vieito, Casal, G. Alonso, Santa Gadea, O. Saavedra, Mirallas, O., Bardaji, M.J. Lostes, Galvao, V., Laimito, K.I. Rojas, Oberoi, A., Pretelli, G., Morillo, B. Ortega, Sanz, M., Izquierdo, S. Aguilar, Raskina, K., Dienstmann, R., Vivancos, A., Tabernero, J., Garralda, E., Calvo, A. Hernando

Get full text

29O Clinical characterization of long-term survivors in phase I clinical trials by Mirallas, O., Rossi, A., Fernández, E.M., Garcia-Galea, E., Cano, K.S. Vega, Moya, J. Ginard, Calvo, A. Hernando, Pretelli, G., Bardaji, M.J. Lostes, Oberoi, A., Galvao, V., Laimito, K.I. Rojas, Morillo, B. Ortega, Casal, G. Alonso, Izquierdo, S. Aguilar, Braña, I., Dienstmann, R., Villar, M. Vieito, Garralda, E.

Get full text

99P Molecular correlates and treatment outcomes of patients with brain metastasis included in early phase trials: A single-center retrospective analysis by Pretelli, G., Laimito, K.I. Rojas, Casal, G. Alonso, Bardaji, M.J. Lostes, Calvo, A. Hernando, Galvao, V., Oberoi, A., Morillo, B. Ortega, Mirallas, O., Santa Gadea, O. Saavedra, Manich, C. Saura, Fernandez, M.E. Elez, Ortiz, C., Couselo, E. Muñoz, Braña, I., Galceran, J.C., Felip, E., Garralda, E., Villar, M. Vieito

Get full text